Drug Approval | August 16, 2021
Zydus Cadila receives final approval for Mesalamine extended-release capsules
The group has a total of 320 ANDA approvals
The group has a total of 320 ANDA approvals
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
Anti-malaria API facility will be operational in 15-18 months
The collaboration will support Canada with direct access to rapid pandemic response capabilities
Filing for WHO Emergency Use Authorisation this month
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
CDSCO to fast-track trials and approval for COVID19 vaccine
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Subscribe To Our Newsletter & Stay Updated
